Table 1 Demographic, surgical, and clinical characteristics of 100 eyes that underwent primary DMEK for FECD
Characteristics | Mean ± SD, median (IQR), or n (%) |
|---|---|
Patient age, years | 72 ± 9 |
Female sex | 61 (61) |
Graft donor age, years | 75 (70–82) |
Origin of the graft, city | |
 Besançon | 55 (55) |
 Nancy | 45 (45) |
Anesthesia | |
 General | 97 (97) |
 Peribulbar | 3 (3) |
Triple DMEK | 43 (43) |
Preoperative BCVA, logMAR | 0.7 (0.5–0.7) |
M12 postoperative BCVA, logMAR | 0.05 (0–0.1) |
M12 BCVA ≤0.1logMAR | 81 (81) |
Preoperative (graft) ECD, cells/mm2 | 2538 ± 207 |
M6 postoperative ECD, cells/mm2 | 1318 ± 431 |
M12 postoperative ECD, cells/mm2 | 1165 ± 402 |
Preoperative CCT, μm | 620 (587–660) |
Postoperative D15 CCT, μm | 600 (550–654) |
Postoperative M12 CCT, μm | 531 (512–559) |
Mean anterior keratometry, D | 43.7 ± 1.5 |
Cystoid macular edema | 4 (4) |
Allograft rejection | 1 (1) |
One or more rebubbling sessions | 30 (30) |
Only one rebubbling session | 21 (21) |
≥2 rebubbling sessions | 9 (9) |